3
Announcements
Trials
Browse
Landscape
Phase
Phase 3
1
Status
Completed
1
Sponsor Class
NETWORK
1
Study Type
Interventional
1
Sponsor
Cancer Type
Gynecologic
1
Gastrointestinal
1
Conditions
Carcinoma, Hepatocellular
2
Squamous Intraepithelial Lesions
1
Papillomavirus Infections
1
HIV Infections
1
Gallbladder Neoplasms
1
Bile Duct Neoplasms
1
Anus Neoplasms
1
Acquired Immunodeficiency Syndrome
1
Interventions
Specimen Handling
4
Magnetic Resonance Spectroscopy
4
Nivolumab
3
Watchful Waiting
2
Light Coagulation
2
Human Papillomavirus Recombinant Vaccine Quadrivalent, Types 6, 11, 16, 18
2
Fluorouracil
2
Biopsy
2
pembrolizumab
1
dehydroftorafur
1
cabozantinib
1
Vorinostat
1
Taxes
1
Sigmoidoscopy
1
Sentinel Lymph Node Biopsy
1
Raltegravir Potassium
1
Radiotherapy, Intensity-Modulated
1
Proctoscopy
1
Papanicolaou Test
1
Paclitaxel
1
Observation
1
Mitozytrex
1
Mitomycin
1
Mass Screening
1
Laser Therapy
1
Isotretinoin
1
Ipilimumab
1
Interferon alpha-2
1
Imiquimod
1
Fluorodeoxyglucose F18
1
Date Range
30 days
90 days
1 year
All
Options
Has results
Has announcements
Clinical Trials
1 trials
Recent
Start date
Enrollment
HIV Infections
×
Laser Therapy
×
Gastrointestinal
×
Clear all
NCT02135419
2024-07-26
ANCHOR
AIDS Malignancy Consortium
Phase 3
Completed
4,446 enrolled
13 charts